Trial record 2 of 46 for:
abbvie abt-450 hiv hcv
Pilot HCV Direct Acting Antiviral Therapy and Metabolism (3D)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02734173 |
|
Recruitment Status :
Completed
First Posted : April 12, 2016
Last Update Posted : August 13, 2019
|
Sponsor:
Ottawa Hospital Research Institute
Collaborator:
AbbVie
Information provided by (Responsible Party):
Ottawa Hospital Research Institute
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | February 2017 |
| Actual Study Completion Date : | May 31, 2017 |